Georgia Retina (01-032) — Marietta, Georgia

Georgia Retina (01-032) is a clinical research site located in Marietta, Georgia, United States 30060.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Georgia Retina (01-032) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Geographic Atrophy.

Sponsors: Apellis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Retina (01-032)?

Georgia Retina (01-032) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Retina (01-032) conducted?

Georgia Retina (01-032) has 1 clinical trials on record, with 1 currently active. Their work covers Geographic Atrophy.

Is Georgia Retina (01-032) accredited by Crixeo Health?

Georgia Retina (01-032) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Retina (01-032)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.